We describe a rapid method for extraction and detection of enterovirus RNA in clinical samples. By using magnetic bead technology, enterovirus RNA was efficiently and rapidly extracted from cerebrospinal fluid, stool, saliva, blood, pericardial fluid, urine, and cryopreserved or formalin-fixed solid tissue. Enterovirus RNA was then detected by reverse transcription followed by polymerase chain reaction amplification with primers designed to allow detection of most enterovirus serotypes. For detection of enteroviruses in specimens from patients with acute enteroviral disease, the overall sensitivity of enzymatic RNA amplification was greater than that of cell culture isolation, especially in blood specimens and in stool specimens from patients with acute cardiac disease. Enterovirus RNA was also detected in cryopreserved and archival formalin-fixed myocardial tissue from patients with acute myocarditis and chronic dilated cardiomyopathy. The ability to study archival specimens is of particular value in conducting retrospective investigation. The RNA extraction procedure used was considerably faster than extraction methods using organic reagents, used less hazardous reagents, and was of similar sensitivity. This detection protocol may therefore be useful both for the diagnosis of enterovirus infection and in studying the pathogenesis of acute and chronic enterovirus-induced disease.
Enteroviruses are important human pathogens; at least 70 serotypes which infect humans have been identified, including the polioviruses, echoviruses, and group A and B coxsackieviruses (CVA and CVB). Acute enterovirus infection may be associated with a broad spectrum of clinical features (reviewed by Grist and Reid [12] ), asymptomatic infection being the most common outcome. There is considerable evidence which suggests that enteroviruses may also cause persistent infection associated with such chronic diseases as dilated cardiomyopathy (DCM) and chronic relapsing pericarditis (reviewed by Muir [23] ), the chronic fatigue syndrome (1, 11, 34) , and more recently the postpolio syndrome (30) .
The laboratory diagnosis of enterovirus infection may be achieved by isolation of virus from cerebrospinal fluid (CSF), blood, or heart or other affected organs. Isolation of virus from stool or throat also provides evidence of infection, but this is less significant, as asymptomatic excretion of enteroviruses is relatively common, particularly during the summer and autumn in temperate climates. However, attempts to isolate enteroviruses are frequently unsuccessful for a number of reasons. Some serotypes grow poorly in cell culture. In many cases infectious virus may no longer be excreted when patients present with symptoms, particularly in patients with cardiac symptoms, which are typically a postacute or chronic manifestation of enterovirus infection.
Serological diagnosis of enterovirus infection is complicated
by the large number of serotypes, the difficulty in demonstrating rising antibody titers in many patients, and the high prevalence of neutralizing antibody in the general population. The most useful serological marker is the presence of enterovirus-specific immunoglobulin M, which indicates a * Corresponding author. current or recent antigenic stimulus (7, 21, 22) , and its persistence may be useful as a marker of chronic enterovirus-induced disease (25) .
There is considerable nucleic acid sequence homology between the enterovirus serotypes, and hybridization probes generated from conserved regions of the enterovirus genome have been shown to be useful in detecting a wide range of enterovirus serotypes (3, 6, 14, 18, 29, 31) . Enterovirus RNA has also been detected by hybridization in the absence of detectable infectious virus or viral antigens in cardiac muscle from patients with viral myocarditis or DCM (3, 19) and in skeletal muscle from patients with inflammatory muscle disease (2, 35) . Polymerase chain reaction (PCR) may also be useful, and several primer pairs and amplification protocols for the detection of enterovirus RNA following cDNA synthesis have been described (4, 13, 28) . By using this technology, enterovirus RNA has been demonstrated in cardiac muscle (17, 32) , skeletal muscle (11) , and stool and CSF (26) . However, the application of PCR to the routine diagnosis of infectious disease has been limited, partly because of the time-consuming nature of sample preparation procedures. In particular, the successful detection of RNA viruses requires laborious RNA extraction procedures using toxic reagents in order to separate viral RNA from RNases and PCR inhibitors present in clinical samples.
To address this issue, we have developed a rapid and simple RNA extraction procedure using reagents of low toxicity and combined this with a reverse transcription and PCR amplification (RT/PCR) protocol using primers homologous to highly conserved regions of the 5' noncoding region of the enterovirus genome. Using this procedure we have detected enterovirus RNA in (i) supernatants of cultures infected with enterovirus reference strains and clinical iso- 
MATERIALS AND METHODS
Virus stocks. CVB types 1 to 6 (Whittaker Bioproducts) were propagated in Vero cells as described previously (24) . The [SDS] ), heated in a boiling water bath for 2 min, and then chilled on ice. For pretreatment of cryopreserved tissue, up to 100 mg of tissue was ground to a fine powder in liquid nitrogen and then homogenized in 100 RI of ice-cold extraction buffer (100 mM Tris [pH 8.0], 500 mM LiCl, 10 mM EDTA, 5 mM dithiothreitol, 10 mM VRC). The homogenate was then clarified by brief centrifugation and chilled on ice.
For pretreatment of formalin-fixed tissue, up to 20 30-pumthick sections were deparaffinized by extracting twice with 10 ml of octane and then twice with 2 ml of absolute ethanol, in a scaled-up version of the method described by Wright and Manos (33) . To approximately 10 mg of tissue was added 100 pI of proteinase K digestion buffer (50 mM Tris [pH 8.5], 1 mm EDTA, 0.5% Tween 20, and 10 mM VRC, with nuclease-free proteinase K [Sigma] added immediately before use to a final concentration of 200 pug/ml), and the mixture was incubated for 3 h at 55°C and then 8 min at 99°C to inactivate proteinase K. The sample was then clarified and chilled on ice. For pretreatment of proteinaceous body fluids such as serum, plasma, and pericardial effusion, 100 pl of sample was mixed with 100 pl of 2x proteinase K digestion buffer containing 400 pug of proteinase K per ml and incubated at 55°C for 1 h and then 99°C for 8 min. The sample was then clarified and chilled on ice. For pretreatment of leukocytes, approximately 106 washed peripheral blood lymphocytes or cells from 1 ml of whole heparinized blood were pelleted by centrifugation, suspended in 200 pl of cold hypotonic lysis buffer (10 mM Tris, pH 7.5; 140 mM NaCl; 5 mM KCI; 1% Nonidet P-40; 10 mM VRC), and incubated on ice for 1 min. Cell nuclei were pelleted by centrifugation, and 100 pul of the supernatant was used for RNA extraction.
Hybridization of enterovirus RNA. Streptavidin-linked magnetic beads (Dynal) coated with a biotinylated oligonucleotide which hybridizes to the 5' noncoding region of many enterovirus RNA genomes (described below) were used for enterovirus RNA hybridization. To 100 ,ul of bead suspen- Elution of bound RNA from the beads was found to be unnecessary and actually resulted in a reduction in the intensity of the PCR product band, since some RNA remained bound after elution. The presence of the beads did not result in any significant inhibition of reverse transcription or PCR amplification. Oligonucleotides. Figure 1 shows the oligonucleotides used for RNA extraction, reverse transcription, PCR amplification, and Southern blot hybridization. Oligonucleotide sequences were based on those described by Rotbart (28 approximately 148-bp PCR product. An amplification protocol using 15-s plateau times resulted in greater PCR product yield than one using 2-min plateau times. Furthermore, at short plateau times, the accumulation of PCR product continued at high cycle numbers: significantly more PCR product was observed after 50 amplification cycles than after 40 cycles, particularly at low input RNA template concentrations.
Southern blot hybridization. To confirm the identity of enterovirus cDNA PCR products, Southern blot hybridization using a biotinylated oligonucleotide which hybridizes to the specific PCR product (Fig. 1) 
RESULTS
Quantitation of RT/PCR sensitivity. Figure 2 shows the results of two titration experiments using CVB type 4 RNA. RNA was extracted with magnetic beads ( Fig. 2A and B) and with RNAzol ( Fig. 2C and D) . RT/PCR was capable of detecting viral RNA extracted from 10 50% tissue culture infective doses ( Fig. 2A) by using magnetic beads after AGE. Following Southern blot hybridization, the sensitivity was increased to 0.1 50% tissue culture infective dose (Fig.   2B ). With RNA prepared with RNAzol B, the sensitivity of RT/PCR was comparable or slightly lower ( Fig. 2C and D Fig. 3 . It can be seen that the use of Southern blot hybridization improves the rate of PCR detection and allows the specific PCR product to be distinguished from nonspecific amplification products. Because some nonspecific amplification products were of sizes similar to that of the specific PCR product, samples were considered positive only when a PCR product of the correct size reacted with the detection probe following Southern blot hybridization.
Overall, the results of RT/PCR compare favorably with those of virus isolation. Enterovirus RNA was detected by RT/PCR in six stool or throat swab specimens in which an enterovirus could not be cultured (patients 3 to 8). In three of these cases there was independent confirmation of the diagnosis of enterovirus infection from examination of other specimens from the same patient: in two cases, an enterovirus was cultured from another specimen from the same patient-from pericardial fluid from patient 4 and from urine and stool from patient 7. In the third case (patient 5) rising enterovirus-specific immunoglobulin M levels were detected in sera collected during convalescence. Although enterovirus RNA could also be detected by RT/PCR in blood components (patient 3), it was not possible to isolate virus, as these specimens were found to be cytotoxic in cell culture. There were, however, three specimens in which an enterovirus was detected by culture but not by RT/PCR. Enterovirus RNA was detected by RT/PCR in endomyo- (34) . It is of interest that stool specimens from three patients with cardiac or skeletal muscle disease did not yield an enterovirus in cell culture but contained enterovirus RNA detectable by RTI PCR (Table 1 , patients 4, 6, and 8). RT/PCR also detected two enterovirus serotypes which could not be typed by two independent laboratories, including one reference laboratory. It is possible that, because of genetic drift, many current enterovirus isolates are antigenically distinct from standard reference strains which were used to generate serotyping antisera. RT/PCR may therefore help to confirm the identity of an enterovirus isolate in such cases. Since 10 of the 11 patients with suspected acute enterovirus infection were adults (Table 2) , it is unlikely that asymptomatic carriage in the gastrointestinal tract or recent poliovirus vaccination accounted for enteroviruses detected in stool or throat swabs.
To our knowledge, there is only one other report of PCR detection of enterovirus in pericardial fluid (26) , and the examination of pericardial fluid by PCR may be useful in establishing a diagnosis of enteroviral heart disease, as well as in studying the pathogenesis of acute and chronic relapsing pericarditis (25) .
There were only three specimens in which an enterovirus was detected by culture but not by RT/PCR (Table 2 , patients 1, 2, and 7), and in only one patient did RT/PCR fail to detect an enterovirus in any specimen ( Table 2 , patient 2). The presence of high levels of RNase activity or of enzymatic inhibitors which copurify with viral RNA in some clinical specimens may limit the sensitivity of RT/PCR, leading to false-negative results. Since many specimens were tested retrospectively in this study, it is also possible that virus and viral RNA was degraded during storage and freeze-thawing. All three culture-positive specimens where RT/PCR failed to detect enterovirus RNA were stool specimens, and it may be that some stool specimens are particularly inhibitory for RT/PCR. Cryopreserved solid tissue can also be processed and analyzed rapidly for the presence of enterovirus RNA. By total RNA extraction methods, the size of tissue sample that can be successfully analyzed is limited, because high RNA concentrations inhibit PCR amplification. However, the use of a selective extraction method as described here, in which most nonspecific RNA is removed, allows larger tissue samples to be analyzed. We have successfully amplified enterovirus RNA from RNA extracts prepared from up to 100 mg of tissue. This may reduce sampling error involved in the detection of focally distributed RNA sequences. However, we have also shown that these methods are sufficiently sensitive to detect enterovirus RNA in endomyocardial bioptome biopsy samples (approximately 1 mg of tissue).
PCR detection of enterovirus RNA in cryopreserved myo-J. CLIN. MICROBIOL. on November 6, 2017 by guest http://jcm.asm.org/ Downloaded from cardial tissue from a small number of patients has been reported previously (17, 32) . However, some recent studies employing PCR to detect enterovirus RNA in biopsy samples from patients with DCM (27) or skeletal muscle biopsy samples from patients with inflammatory muscle disease (20) have failed to demonstrate the association with the presence of enterovirus RNA reported in nucleic acid hybridization studies. This may be due to differences in the relative sensitivity and specificity of hybridization and PCR assays or differences in the patients studied. Clearly, parallel studies in which the same patients are studied by both PCR and hybridization methods will be required to resolve these apparent contradictions.
The ability to study formalin-fixed tissue by PCR for the presence or viral RNA is of major significance, as this allows archival tissue to be examined, considerably increasing the possible scope of investigation. The amplification of measles virus RNA from formalin-fixed tissue has been reported (15) . We now report the successful amplification of enterovirus RNA from formalin-fixed tissue by a considerably shorter extraction procedure.
The speed and sensitivity of this protocol and its ability to detect enterovirus RNA in tissue and other specimens from which virus cannot be cultured must be offset against the high cost of PCR reagents. The risk of false-positive results due to PCR contamination must also be rigorously excluded.
Positive results were not observed in the extraction or reagent blanks included in these experiments. We are continuing our studies in order to accumulate a larger body of data. This will give a clearer indication of the feasibility of using this protocol for the laboratory diagnosis of enterovirus infection.
As the sequence of the capture oligonucleotide used here is conserved among enteroviruses and rhinoviruses, this extraction procedure may also be useful for the detection of rhinovirus RNA in conjunction with appropriate PCR primers (10, 13, 26) . The principle of selective RNA hybridization should also be useful for the isolation and detection of other viral or cellular RNA species.
